Cell And Gene Therapy Videos

  1. A Concept-To-Commercial Gene Therapy CDMO 7/28/2025

    The Curator™ adherent platform has been used to manufacture more than 450 Phase 1 and 2 clinical batches, spanning over 17 years and covering a variety of serotypes and indications.

  2. ReciBioPharm Capacity Update July 2025: Analytical Services 7/28/2025

    ReciBioPharm’s specialized CDMO capabilities include development and manufacture for new biological modalities. Discover the benefits of choosing a CDMO with complete end-to-end services and in-house analytical capabilities.

  3. Alcami Capacity Update July 2025: Analytical Services 7/28/2025

    Alcami’s laboratory services can support many drug substance or drug product modalities, all product phases, and specialty laboratory services, including in-house microbiology, raw materials, and analytical development.

  4. Maximizing Results For Viral Clearance Studies 7/25/2025

    Explore virus strain selection and titer strategies to optimize viral clearance studies, covering regulatory expectations, study design, and execution best practices.

  5. Together, Let's Sail Toward Success 7/23/2025

    Explore the promise and complexity of gene therapy and see how Cytiva empowers scientists to overcome challenges and accelerate life-changing treatments from lab to patient.

  6. Practical Applications For Controlled And Safe Nucleic Acid Delivery 7/21/2025

    Explore the science behind LNP formulation development, from ionizable lipids to scalable manufacturing through case studies, screening strategies, and flexible approaches for advancing next-generation therapeutics.

  7. CRISPR Meets LNPs: A New Era In Cell And Gene Therapies 7/8/2025

    Explore how lipid nanoparticles are revolutionizing non-viral gene editing with scalable, efficient delivery for both ex vivo and in vivo applications, which features new CRISPR-LNP data in T cells.

  8. Integrated Technologies And Glycosylation Tuning In Upstream Bioprocessing 7/1/2025

    Optimize mAb production with innovative cell culture media and feed designs. Explore integrated technologies, intensified fed-batch approaches, and methods to modulate glycosylation profiles in upstream bioprocessing.

  9. The World Outside Influencing Your Outsourcing Internals 6/26/2025

    Tariffs, geopolitical gyrations, (pending) laws such as the BIOSECURE Act; all affect your outsourcing optionality and decision-making. Our panel of internationally savvy biopharma executives provide some guiding insights.

  10. Your CDMO Knows A Lot - Are You Listening? 6/26/2025

    Our three experienced panelists weigh in on how sponsors should take advantage of what CDMOs know from experience in quality, regulatory, and other aspects of development and processing.